Arivale Inc. — Form D
Arivale Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-07-16. The offering totals $36.0M, of which $17.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2015-07-16
- Form: D
- Accession: 0001647380-15-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $36.0M
- Amount sold: $17.0M
- Remaining: $19.0M
- Investors: 6
- Date of first sale: 2015-06-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-243907
Issuer
- Name: Arivale Inc.
- CIK: 0001647380
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Incorporated: 2013
- Address: 710 SECOND AVE STE. 410, SEATTLE, WA, 98104
- Phone: 206-981-5821
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Robert Nelsen | Director | Seattle, WA |
| Dan Levitan | Director | San Francisco, CA |
| Terry McGuire | Director | Waltham, MA |
| Clayton Lewis | Director | Yorba Linda, CA |
| Clayton Lewis | Executive Officer | Yorba Linda, CA |
| Nathan Price | Director | Seattle, WA |
| Tim Kilgallon | Director | Norwell, MA |
Other filings by this issuer (1)
More